RUBIUS THERAPEUTICS
Startup
RUBIUS THERAPEUTICS
Description
Rubius Therapeutics develops red cell therapeutics (RCTs) which are engineered red blood cells designed to express biotherapeutic proteins within or on their cell surface to create highly selective, potent and allogeneic cellular medicines in order to treat rare diseases, cancer, and autoimmune diseases.
Resources
RUBIUS THERAPEUTICS
Address
United States
Contact
info@rubiustx.com
Description
Rubius Therapeutics develops red cell therapeutics (RCTs) which are engineered red blood cells designed to express biotherapeutic proteins within or on their cell surface to create highly selective, potent and allogeneic cellular medicines in order to treat rare diseases, cancer, and autoimmune diseases.
Resources
Matchmaking
Connect with RUBIUS THERAPEUTICS
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways